LeMaitre Vascular's Upcoming Investor Engagements and Insights

Engagements Ahead: LeMaitre Vascular's Investor Conferences
LeMaitre Vascular, Inc. (NASDAQ: LMAT) has exciting plans as it gears up for important investor conferences this March. The management is preparing to engage with stakeholders and showcase their innovative products aimed at treating peripheral vascular disease. As a leader in this field, LeMaitre is committed to advancing medical solutions for over 200 million people affected worldwide.
Highlights of the Upcoming Conferences
37th Annual ROTH Conference
The first event on the calendar is the prestigious 37th Annual ROTH Conference scheduled for March 17, 2025. This gathering will take place at The Laguna Cliffs Marriott in Dana Point, California. LeMaitre's management team is set to present at 4:00 PM PDT, sharing the company’s vision and recent advancements in vascular technology.
KeyBanc Healthcare Forum
Following the ROTH Conference, the team will participate in the KeyBanc Healthcare Forum on March 19, 2025. This virtual event provides a unique platform for discussing innovations and opportunities in healthcare. LeMaitre's presentation is scheduled for 1:30 PM EDT, offering insights into their strategic direction and product offerings.
Oppenheimer Annual Healthcare MedTech & Services Conference
Lastly, on March 20, 2025, the Oppenheimer 35th Annual Healthcare MedTech & Services Conference will take place virtually. At 10:00 AM EDT, management will outline their growth initiatives and key developments in vascular care, emphasizing the importance of their devices in enhancing patient outcomes.
Understanding LeMaitre Vascular's Role in Healthcare
LeMaitre is dedicated to the development, manufacturing, and marketing of medical devices that focus on peripheral vascular disease treatment. Their products are designed specifically for vascular surgeons, addressing critical needs in patient care. With a strong commitment to innovation, LeMaitre continually strives to provide advanced solutions that enhance the quality of care.
Company Contact Information
For more information about LeMaitre Vascular, interested parties may contact:
Greg Manker
Director Business Development & Investor Relations
LeMaitre Vascular, Inc.
Phone: (781) 362-1260
Email: gmanker@lemaitre.com
Frequently Asked Questions
What is LeMaitre Vascular known for?
LeMaitre Vascular is recognized for its innovative devices and services targeting peripheral vascular diseases, which affect millions globally.
When will LeMaitre Vascular present at investor conferences?
LeMaitre will participate in a series of conferences on March 17, 19, and 20, 2025, presenting their advancements and strategies.
How does LeMaitre Vascular impact patient care?
LeMaitre Vascular's products are geared toward improving surgical outcomes for patients suffering from vascular diseases, enhancing quality of life.
Who can I contact for more information about LeMaitre Vascular?
For inquiries, contact Greg Manker, Director of Business Development at LeMaitre Vascular via email or phone.
Is LeMaitre Vascular publicly traded?
Yes, LeMaitre Vascular is publicly traded on NASDAQ under the ticker LMAT, reflecting its commitment to transparency and growth in the healthcare sector.
About The Author
Contact Olivia Taylor privately here. Or send an email with ATTN: Olivia Taylor as the subject to contact@investorshangout.com.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.